YILDIZ, O. Et Al. 2017. Paritaprevir/ritonavir/ombitasvir – dasabuvir (PrOD) withor without ribavirin treatment in hemodialysis patientswith chronic hepatitis C virus infection: case reports. 26 th Annual Conference of APASL , (China), 1-1093.

YILDIZ, O., AYGEN, B., GÖKAHMETOĞLU, S., türe, Z., BALTACI, S., & tok, t., (2017). Paritaprevir/ritonavir/ombitasvir – dasabuvir (PrOD) withor without ribavirin treatment in hemodialysis patientswith chronic hepatitis C virus infection: case reports . 26 th Annual Conference of APASL (pp.1-1093). , China

YILDIZ, ORHAN Et Al. "Paritaprevir/ritonavir/ombitasvir – dasabuvir (PrOD) withor without ribavirin treatment in hemodialysis patientswith chronic hepatitis C virus infection: case reports," 26 th Annual Conference of APASL, China, 2017

YILDIZ, ORHAN Et Al. "Paritaprevir/ritonavir/ombitasvir – dasabuvir (PrOD) withor without ribavirin treatment in hemodialysis patientswith chronic hepatitis C virus infection: case reports." 26 th Annual Conference of APASL , China, pp.1-1093, 2017

YILDIZ, O. Et Al. (2017) . "Paritaprevir/ritonavir/ombitasvir – dasabuvir (PrOD) withor without ribavirin treatment in hemodialysis patientswith chronic hepatitis C virus infection: case reports." 26 th Annual Conference of APASL , China, pp.1-1093.

@conferencepaper{conferencepaper, author={ORHAN YILDIZ Et Al. }, title={Paritaprevir/ritonavir/ombitasvir – dasabuvir (PrOD) withor without ribavirin treatment in hemodialysis patientswith chronic hepatitis C virus infection: case reports}, congress name={26 th Annual Conference of APASL}, city={}, country={China}, year={2017}, pages={1-1093} }